Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013, Article ID 306385, 12 pages
http://dx.doi.org/10.1155/2013/306385
Research Article

Sparfloxacin-Metal Complexes as Urease Inhibitors: Their Synthesis, Characterization, Antimicrobial, and Antienzymatic Evaluation

1Faculty of Pharmacy, Jinnah University for Women, Karachi 74600, Pakistan
2United Biotechnologies, Karach-75270, Pakistan
3Dow College of Pharmacy, Dow University of Health Sciences, Karachi 74200, Pakistan
4H.E.J Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan

Received 29 May 2013; Revised 10 September 2013; Accepted 15 September 2013

Academic Editor: Stavros Lalas

Copyright © 2013 Somia Gul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kang, L. Wang, X.-L. Chen, D. J. Triggle, and D. Rampe, “Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG,” Molecular Pharmacology, vol. 59, no. 1, pp. 122–126, 2001. View at Google Scholar · View at Scopus
  2. W. Mertz, “Review of the scientific basis for establishing the essentiality of trace elements,” Biological Trace Element Research, vol. 66, no. 1–3, pp. 185–191, 1998. View at Google Scholar · View at Scopus
  3. E. K. Efthimiadou, Y. Sanakis, N. Katsaros, A. Karaliota, and G. Psomas, “Transition metal complexes with the quinolone antibacterial agent pipemidic acid: synthesis, characterization and biological activity,” Polyhedron, vol. 26, no. 5, pp. 1148–1158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. S. Arayne, N. Sultana, and F. Hussain, “In vitro monitoring of ciprofloxacin antacids interactions by UV & HPLC,” Pakistan Journal of Pharmaceutical Sciences, vol. 18, no. 4, pp. 23–31, 2005. View at Google Scholar · View at Scopus
  5. J. Al-Mustafa, “Magnesium, calcium and barium perchlorate complexes of ciprofloxacin and norfloxacin,” Acta Chimica Slovenica, vol. 49, no. 3, pp. 457–466, 2002. View at Google Scholar · View at Scopus
  6. S. Sagdinca and S. Bayarýb, “Spectroscopic studies on the interaction of ofloxacin with metals,” Journal of Molecular Structure, vol. 691, no. 1–3, pp. 107–113, 2004. View at Publisher · View at Google Scholar
  7. I. Turel, “The interactions of metal ions with quinolone antibacterial agents,” Coordination Chemistry Reviews, vol. 232, no. 1-2, pp. 27–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Macías, M. V. Villa, I. Rubio, A. Castiñeiras, and J. Borrás, “Complexes of Ni(II) and Cu(II) with ofloxacin: crystal structure of a new Cu(II) ofloxacin complex,” Journal of Inorganic Biochemistry, vol. 84, no. 3-4, pp. 163–170, 2001. View at Google Scholar · View at Scopus
  9. N. Sultana, M. S. Arayne, S. Gul, and S. Shamim, “Sparfloxacin-metal complexes as antifungal agents—their synthesis, characterization and antimicrobial activities,” Journal of Molecular Structure, vol. 975, no. 1–3, pp. 285–291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Hoffken, K. Borner, P. D. Glatzel, P. Koeppe, and H. Lode, “Reduced enteral absorption of ciprofloxacin in the presence of antacids,” European Journal of Clinical Microbiology, vol. 4, no. 3, p. 345, 1985. View at Google Scholar · View at Scopus
  11. H. H. M. Ma, F. C. K. Chiu, and R. C. Li, “Mechanistic investigation of the reduction in antimicrobial activity of ciprofloxacin by metal cations,” Pharmaceutical Research, vol. 14, no. 3, pp. 366–370, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. H. N. Alkaysi, M. H. Abdel-Hay, M. Sheikh Salem, A. M. Gharaibeh, and T. E. Na'was, “Chemical and microbiological investigations of metal ion interaction with norfloxacin,” International Journal of Pharmaceutics, vol. 87, no. 1–3, pp. 73–77, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. E. K. Efthimiadou, A. Karaliota, and G. Psomas, “Mononuclear dioxomolybdenum(VI) complexes with the quinolones enrofloxacin and sparfloxacin: synthesis, structure, antibacterial activity and interaction with DNA,” Polyhedron, vol. 27, no. 1, pp. 349–356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. K. Efthimiadou, Y. Sanakis, N. Katsaros, A. Karaliota, and G. Psomas, “Transition metal complexes with the quinolone antibacterial agent pipemidic acid: synthesis, characterization and biological activity,” Polyhedron, vol. 26, no. 5, pp. 1148–1158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. K. Efthimiadou, Y. Sanakis, C. P. Raptopoulou, A. Karaliota, N. Katsaros, and G. Psomas, “Crystal structure, spectroscopic, and biological study of the copper(II) complex with third-generation quinolone antibiotic sparfloxacin,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 14, pp. 3864–3867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. K. Efthimiadou, M. E. Katsarou, A. Karaliota, and G. Psomas, “Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: structure-activity relationship,” Journal of Inorganic Biochemistry, vol. 102, no. 4, pp. 910–920, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. C. Skyrianou, E. K. Efthimiadou, V. Psycharis, A. Terzis, D. P. Kessissoglou, and G. Psomas, “Nickel-quinolones interaction—part 1: nickel(II) complexes with the antibacterial drug sparfloxacin: structure and biological properties,” Journal of Inorganic Biochemistry, vol. 103, no. 12, pp. 1617–1625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Psomas, “Mononuclear metal complexes with ciprofloxacin: synthesis, characterization and DNA-binding properties,” Journal of Inorganic Biochemistry, vol. 102, no. 9, pp. 1798–1811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. N. Alkaysi, M. H. Abdel-Hay, M. Sheikh Salem, A. M. Gharaibeh, and T. E. Na'was, “Chemical and microbiological investigations of metal ion interaction with norfloxacin,” International Journal of Pharmaceutics, vol. 87, no. 1–3, pp. 73–77, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Turel, “The interactions of metal ions with quinolone antibacterial agents,” Coordination Chemistry Reviews, vol. 232, no. 1-2, pp. 27–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Turel, I. Leban, and N. Bukovec, “Synthesis, characterization, and crystal structure of a copper(II) complex with quinolone family member (ciprofloxacin): bis(1-cyclopropyl-6-fluoro- 1,4-dihydro-4-oxo-7-piperazin-1ylquinoline-3-carboxylate) copper(II) chloride hexahydrate,” Journal of Inorganic Biochemistry, vol. 56, no. 4, pp. 273–282, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Turel, K. Gruber, I. Leban, and N. Bukovec, “Synthesis, crystal structure, and characterization of three novel compounds of the quinolone family member (norfloxacin),” Journal of Inorganic Biochemistry, vol. 61, no. 3, pp. 197–212, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. S. C. Wallis, L. R. Gahan, B. G. Charles, and T. W. Hambley, “Synthesis and X-ray structural characterization of an iron(III) complex of the fluoroquinolone antimicrobial ciprofloxacin,” Polyhedron, vol. 14, no. 20-21, pp. 2835–2840, 1995. View at Google Scholar · View at Scopus
  24. S. C. Wallis, L. R. Gahan, B. G. Charles, T. W. Hambley, and P. A. Duckworth, “Copper(II) complexes of the fluoroquinolone antimicrobial ciprofloxacin. Synthesis, X-ray structural characterization, and potentiometric study,” Journal of Inorganic Biochemistry, vol. 62, no. 1, pp. 1–16, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. Z.-F. Chen, R.-G. Xiong, J. Zhang, X.-T. Chen, Z.-L. Xue, and X.-Z. You, “2D molecular square grid with strong blue fluorescent emission: a complex of norfloxacin with zinc(II),” Inorganic Chemistry, vol. 40, no. 16, pp. 4075–4077, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Macías, M. V. Villa, I. Rubio, A. Castiñeiras, and J. Borrás, “Complexes of Ni(II) and Cu(II) with ofloxacin: crystal structure of a new Cu(II) ofloxacin complex,” Journal of Inorganic Biochemistry, vol. 84, no. 3-4, pp. 163–170, 2001. View at Publisher · View at Google Scholar
  27. L.-Z. Wang, Z.-F. Chen, X.-S. Wang, Y.-H. Li, R.-G. Xiong, and X.-Z. You, “2D nanoporous molecular square grid: manganese (II) norfloxacin complex,” Chinese Journal of Inorganic Chemistry, vol. 18, no. 12, pp. 1185–1190, 2002. View at Google Scholar · View at Scopus
  28. M. S. Arayne, N. Sultana, and F. Hussain, “Interactions between sparfloxacin and antacids: dissolution and adsorption studies,” Pakistan Journal of Pharmaceutical Sciences, vol. 19, no. 1, pp. 16–21, 2006. View at Google Scholar · View at Scopus
  29. S. Arayne, N. Sultana, U. Haroon, and M. A. Mesaik, “Synthesis, characterization, antibacterial and anti-inflammatory activities of enoxacin metal complexes,” Bioinorganic Chemistry and Applications, vol. 2009, Article ID 914105, 6 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Sultana, A. Naz, M. S. Arayne, and M. A. Mesaik, “Synthesis, characterization, antibacterial, antifungal and immunomodulating activities of gatifloxacin-metal complexes,” Journal of Molecular Structure, vol. 969, no. 1–3, pp. 17–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” The American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–496, 1966. View at Google Scholar · View at Scopus
  32. National Committee on Clinical Laboratory Standards, Performance Standards for Antimicrobial Disk Susceptibility Tests, NCCLS, Villanova, Pa, USA, 1983.
  33. LMD Victor Antibiotics in Laboratory Medicine, Williams and Wilkins, 3rd edition, 1991.
  34. E. K. Efthimiadou, A. Karaliota, and G. Psomas, “Structure, antimicrobial activity and DNA-binding properties of the cobalt(II)-sparfloxacin complex,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 14, pp. 4033–4037, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. E. K. Efthimiadou, Y. Sanakis, C. P. Raptopoulou, A. Karaliota, N. Katsaros, and G. Psomas, “Crystal structure, spectroscopic, and biological study of the copper(II) complex with third-generation quinolone antibiotic sparfloxacin,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 14, pp. 3864–3867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. E. K. Efthimiadou, M. E. Katsarou, A. Karaliota, and G. Psomas, “Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: structure-activity relationship,” Journal of Inorganic Biochemistry, vol. 102, no. 4, pp. 910–920, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Jain, N. K. Jain, and K. S. Pitre, “Bio-inorganic studies on the Fe(II) sparfloxacin complex,” Metal-Based Drugs, vol. 9, no. 1-2, pp. 1–8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Prestch, T. Clerc, J. Seibl, and W. Simon, Tablas de Determinacion Estructural Por Metodos Espectroscopicos, Springer, Barcelona, Spain, 1998.
  39. N. Jiménez-Garrido, L. Perelló, R. Ortiz et al., “Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin,” Journal of Inorganic Biochemistry, vol. 99, no. 3, pp. 677–689, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Saeed Arayne, N. Sultana, and A. Zeeshan Mirza, “Preparation and spectroscopic characterization of metal complexes of gliquidone,” Journal of Molecular Structure, vol. 927, no. 1-3, pp. 54–59, 2009. View at Publisher · View at Google Scholar · View at Scopus